Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24556041

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2014 Mar
First author
Conroy T

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Dec;15(13):e587
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet Oncol. 2014 Mar;15(3):248-9. doi: 10.1016/S1470-2045(14)70064-6.
    note
    Source null
    related pmid
    24556038
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2014 Dec;15(13):e587. doi: 10.1016/S1470-2045(14)71151-9.
    note
    Source null
    related pmid
    31288369
    relationship
    Erratum in

Authors and identifiers

  1. name
    Conroy T
    type
    Author
  2. name
    Galais MP
    type
    Author
  3. name
    Raoul JL
    type
    Author
  4. name
    Bouché O
    type
    Author
  5. name
    Gourgou-Bourgade S
    type
    Author
  6. name
    Douillard JY
    type
    Author
  7. name
    Etienne PL
    type
    Author
  8. name
    Boige V
    type
    Author
  9. name
    Martel-Lafay I
    type
    Author
  10. name
    Michel P
    type
    Author
  11. name
    Llacer-Moscardo C
    type
    Author
  12. name
    François E
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Conroy T
    type
    Author
  2. name
    Galais MP
    type
    Author
  3. name
    Raoul JL
    type
    Author
  4. name
    Bouché O
    type
    Author
  5. name
    Gourgou-Bourgade S
    type
    Author
  6. name
    Douillard JY
    type
    Author
  7. name
    Etienne PL
    type
    Author
  8. name
    Boige V
    type
    Author
  9. name
    Martel-Lafay I
    type
    Author
  10. name
    Michel P
    type
    Author
  11. name
    Llacer-Moscardo C
    type
    Author
  12. name
    François E
    type
    Author
bibliography ids
  1. nci-bib-138bd639226a7a5251f57cbd
book metadata
content sha256
10de1a4d10b13104b0f4b7db0641d89ad921027ea940b3df0820b3239cf21329
document type
citation
dois
  1. 10.1016/S1470-2045(14)70028-2
electronic publication date
display
2014 Feb 18
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24556041
immutable id
pubmed:24556041@10de1a4d10b13104b0f4b7db0641d89ad921027ea940b3df0820b3239cf21329
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
3
name
The Lancet. Oncology
nlm unique id
100957246
pages
305-14
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Dec;15(13):e587
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet Oncol. 2014 Mar;15(3):248-9. doi: 10.1016/S1470-2045(14)70064-6.
    note
    Source null
    related pmid
    24556038
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2014 Dec;15(13):e587. doi: 10.1016/S1470-2045(14)71151-9.
    note
    Source null
    related pmid
    31288369
    relationship
    Erratum in
outcomes validated
false
pmid
24556041
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
b2ea478be451e9a7de4cef2e56fdab9259ef9d3ea3b5f91c4161ab74187c66a9
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 Mar
precision
month
year
2014
publication types
  1. Clinical Trial, Phase II
  2. Clinical Trial, Phase III
  3. Comparative Study
  4. Journal Article
  5. Multicenter Study
  6. Randomized Controlled Trial
  7. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24556041/
title
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.

Preserved source evidence · Not medical advice